P-LLY Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about orforglipron as a potential treatment for adults with type 2 diabetes, and the timeline for regulatory submissions and actions, future readouts, presentations, and other milestones relating to orforglipron and its clinical trials and reflects Lilly's current beliefs and expectations
A 2mg/mL concentration (5mg vial in 2.5mL BAC water) requires a 1mL injection for a 2mg dose, while a 4mg/mL concentration (10mg vial in 2.5mL) requires only 0.5mL for the same 2mg dose
California is joining several other states in restricting an option they say is no longer affordable as they confront soaring pharmaceutical costs and steep Medicaid cuts under the Trump administration, among other financial pressures
In my 20+ years of practice treating obesity and weight-related conditions, Ive observed that true transformation requires frequent adjustmentsespecially when nutrition, medications, and hormones all interact
With that effectiveness comes a side effect profile that is real, common, and frequently underexplained to patients before they start treatment
Personalized Nutrition Guidance Nutrition remains one of the most important components of any weight management strategy